Dream big,
think concretely,
work hard.
Vision is a company of down-to-earth dreamers established in 2022. We are dreamers because we dream of a world in which cancer kills fewer people than it does today and because we want treatments that can be available to all patients.
Meet our Team
Destroys tumor masses
with radio frequences
Nanoradox is a Class III medical device that, in in-vivo studies, shows an inhibition of the growth of the tumor mass by over 50%.
Nanoradox is a non-invasive, non-toxic hyperemic treatment that can support pharmacological therapies. It is essential for extending patients’ lives and significantly increasing their quality of life during and after the illness.
Patent pending n. 23157097.9
New frontiers in oncological research
Simplicity is the ultimate sophistication
Leonardo Da Vinci
